Subscribe to news

Press Releases

22.12.2016
Human Stem Cells Institute Becomes a Stockholder in Artgen, Inc.
09.12.2016
HSCI Announces 9mo 2016 Consolidated Results under IFRS
12.10.2016
Human Stem Cells Institute Licenses Its Innovative Ischemia Drug to ArtGen, Inc. for Development in the United States and Canada
12.09.2016
Human Stem Cells Institute (HSCI) announced that HSCI’s GENETICO Medical Center & Testing Lab has received 300 million rubles from the Russian State Industry Development Fund.
31.08.2016
PJSC HSCI, announced its unaudited consolidated interim results for the first half of 2016 in accordance with the International Financial Reporting Standards (IFRS).
05.08.2016
PJSC HSCI – The Human Stem Cells Institute (“HSCI”, MOEX: ISKJ), one of Russia’s leading biotech companies, announced its plans to raise capital for growth by holding secondary public offering (SPO) on the Moscow Exchange in autumn 2016.
02.08.2016
PJSC HSCI, announced its unaudited unconsolidated results for the first half of 2016 in accordance with the Russian Accounting Standards (RAS):
16.06.2016
PJSC HSCI today announced the results of the Annual General Shareholders’ Meeting (AGM) held on June 16, 2016 in Moscow.
03.06.2016
PJSC HSCI, today announced its unaudited consolidated interim results for the first quarter of 2016 in accordance with the International Financial Reporting Standards (IFRS).